for expensive complications, and improved emotional well being (NDEP, 1999) . Because of the amount of time an employee spends at the workplace, it is critical that systems be in place to support employees in adopting behaviors that promote effective diabetes control (NDEP, 1999) .
TYPES OF DIABETES
There are primarily two types of diabetes, type I and type 2. The majority of individuals diagnosed with diabetes are classified as type 2. Type 2 diabetes is a disease of relative insulin insufficiency caused by insulin resistance, beta cell dysfunction, and excessive hepatic glucose production (American Association of Diabetes Educators [AADE), 2003) . Historically, this disease has presented in obese, sedentary individuals older than age 30, though it is becoming more common in children and adolescents because of the increased incidence of childhood obesity.
The onset of type 2 diabetes is often preceded by insulin resistance syndrome and "pre-diabetes." Insulin resistance syndrome is a metabolic condition including a combination of obesity, increased waist circumference, hypertension, and hyperlipidemia. "Pre-diabetes," impaired fasting glucose or impaired glucose tolerance, can be described as blood glucose levels higher than normal, but not high enough to be diagnostic for diabetes (National Institutes of Diabetes and Digestive and Kidney Diseases, 2003) . Current research supports early intervention for prevention of type 2 diabetes. The National Diabetes Prevention Program demonstrated that increased physical activity and nutrition changes leading to a modest weight loss helped to delay or prevent the onset of type 2 diabetes (American Diabetes Association [ADA], 2002) .
Type 1 diabetes, most often diagnosed before age 30, is a disease characterized by autoimmune destruction of the insulin producing beta cells of the pancreas. Individuals may present with weight loss, polydipsia, polyuria, polyphagia, and sometimes ketoacidosis. Individuals with type 1 diabetes are dependent on exogenous insulin for survival (AADE, 2003) .
DIAGNOSIS AND CLASSIFICATION
The insidious onset of type 2 diabetes contributes to many of the complications often present at diagnosis. Therefore, the American Diabetes Association recommends that all individuals be screened at 3 year intervals beginning at age 45 (2004) . Individuals who are overweight, with additional risk factors for diabetes, should be screened at an earlier age and more frequently (see Table 1 ). Screening for diabetes includes fasting plasma glucose (FPG), casual plasma glucose, or the 75 oral glucose tolerance test.
A diagnosis of diabetes is made when any of the following criteria are met: • FPG greater than 126 mg/dL on two separate occasions.
• Casual blood glucose level greater than 200 mg/dL. • 2 hour post prandial glucose greater than 200 mg/dL with symptoms of diabetes (see Table 2 ).
Diabetes requires continuing health care and self management education to reduce acute and chronic complications of the disease (ADA, 2004) . Achieving positive diabetes outcomes often requires lifestyle changes related to nutrition and physical activity. This, in addition to self blood glucose monitoring (SBGM), medication therapy if necessary, and diabetes self management education (DSME) provided by a Certified Diabetes Educator (CDE) can lead to decreased health care expenditures, higher productivity, and improved quality of life.
NUTRITION
Nutrition therapy is the cornerstone of diabetes management. Therefore, it is important for all members of the health care team to be familiar with diabetes nutrition guidelines. Because of the complexity of nutrition and the importance of tailoring a meal plan to an individual's 
Risk Factors for Type 2 Diabetes
• Age> 45 years.
• Overweight (body mass index> 25 kg/m).
• Family history of diabetes.
• Habitual sedentary lifestyle/physical inactivity.
• Race/ethnicity (African American, Hispanic American, Native American, Asian American, or Pacific Islander).
• Previously identified impaired fasting glucose or impaired glucose tolerance.
• History of gestational diabetes or a baby weighing > 91b.
• Hypertension (> 140/90 mmHg in adults).
• HDL cholesterol < 35 mg/dL and or triglycerides > 250 mg/dL.
• Polycystic ovary syndrome.
• History of vascular disease. (American Diabetes Association, 2004) .
food, cultural, and ethnic preferences and their individual circumstances, a referral to a registered dietitian for medical nutrition therapy (MNT) is preferred. Goals of MNT include assisting the individual to achieve and maintain optimal metabolic outcomes related to blood glucose, lipid, and blood pressure levels that prevent or reduce the risk for diabetes complications. In addition, MNT supports improving health through healthy food choices and physical activity while maintaining sensitivity to cultural, ethnic, and lifestyle preferences. Modifications are made to prevent and treat the chronic complications of diabetes while supporting individual nutrition needs (ADA, 2004) . For an individual with type I diabetes, nutntion plans are based on the individual's usual food intake and activity level. The insulin regimen should be designed to meet individual lifestyle and glycemic goals. Nutrition for the person with type 2 diabetes targets lifestyle changes, blood pressure management, lipid management, and weight loss.
Many types of nutrition plans are used for individuals with diabetes including carbohydrate counting, glycemic index, total available glucose, exchange method, portion control, and the food guide pyramid. Current trends lead toward carbohydrate counting using a consistent carbohydrate intake throughout the day. Recommended nutrient intake for the person with diabetes is (ADA,2004): • 60% to 70% carbohydrate and monounsaturated fat. • 15% to 20% protein.
• 30% fat with less than 10% coming from saturated fat.
Carbohydrates are the nutrient source having the greatest effect on post prandial blood glucose. Therefore, it is important for the person with diabetes to have an understanding of what foods contain carbohydrates and how much carbohydrate they contain. Carbohydrate containing foods include starches, fruits, milk, vegetables. and other foods such as sweets or snacks. Many myths exist related to the consumption of simple carbohydrates or sweets by individuals with diabetes.
It is currently known that the total amount of carbohydrate in meals or snacks is more important than the source or the type of carbohydrate. Therefore, because sucrose does not increase the blood glucose more than the same amount of carbohydrate from starch, sucrose containing foods are not restricted, but are substituted for other carbohydrate sources. For example one cup of com flakes cereal and three small cookies both contain 23 grams of carbohydrate and will have similar effects on blood glucose levels.
In general, individuals with diabetes should eat an overall healthy meal plan as recommended for all Americans. This should include fruits, vegetables, fiber filled grains. low fat dairy products, and meat or other protein sources. Fats, oils, and sweets should be consumed sparingly (U.S. Department of Agriculture, 2000). Portion control is extremely important for blood glucose and weight control.
PHYSICAL ACTIVITY
Exercise is an often under utilized way to manage diabetes and achieve improved glucose control. Before increasing usual patterns of physical activity, individuals with diabetes should receive a complete medical examination. This allows tailoring the exercise plan to the individual's needs and takes into consideration exercise adaptations related to diabetes complications. Physical activity decreases insulin resistance, allowing for better insulin use.
Because of increased insulin sensitivity, individuals treated with medication may be more likely to experience hypoglycemia for up to 24 hours following exercise. Therefore, an individual beginning an exercise program may require a medication adjustment. The current rec-ommendation is that individuals accumulate 30 minutes of physical activity on most days (CDC, 1999) . The type of activity should be chosen based on personal preference and may include activities such as walking, jogging, swimming, or gardening.
MONITORING
Routine monitoring is essential to diabetes management. This includes SBOM, reviewing blood glucose patterns, and monitoring urine ketones when necessary. Urine glucose testing is not reflective of current blood glucose levels. Therefore, it is not recommended as a method for monitoring glycemic control. SBGM provides immediate feedback and data for evaluating medication needs, determining response to food or physical activity, and preventing or detecting hypoglycemia (AADE, 2003) . The frequency and timing of SBGM is determined by how the information obtained will be used. Insulin users can use pre and post prandial SBOM to help determine needed insulin adjustments. Noninsulin users may benefit more from post prandial monitoring to evaluate glycemic excursions caused by diet or physical activity. Monitoring is based on the individual's needs, schedule. and planned use of the data. For this reason, many meters and data management systems exist for analysis and data storage.
Ketone testing remains an important component of diabetes care. Individuals with type I diabetes are prone to ketosis and individuals with type 2 diabetes are ketosis resistant, although they may develop ketosis during times of severe illness or trauma. Routine monitoring for urine ketones is recommended for all individuals with diabetes, especially during times of illness or trauma. Individuals with type I diabetes should also monitor for urine ketones when blood glucose levels are greater than 300 mg/dL (ADA, 2003) . Individuals with diabetes should develop a sick day/ketone management plan with their health care provider.
MEDICATION THERAPY
For many individuals with diabetes, glycemic control can be maintained with non-pharmacologic interventions such as MNT. physical activity, and SBOM. However, a majority of individuals with diabetes require treatment with pharmacologic means in addition to the recommended lifestyle modification interventions (AADE, 2003) . Therapy for individuals with type 2 diabetes may consist of a single agent or a combination of oral agents and insulin. However, over time, most will require insulin to reach target glucose goals. Currently, treatment consists of using multiple oral agents focusing on treating the dual defects associated with type 2 diabetes. New medication options include combinations of available preparations (see Table 3 ). Type I diabetes is treated with insulin in addition to the recommended non-pharmacologic interventions.
Oral Agents
Currently, there are six classes of oral agents: • Biguanides. Agents are classified according to their site of action targeting the defects of insulin resistance, increased hepatic glucose production, and decreased pancreatic insulin secretion. Biguanides and thiazolidinediones are both insulin sensitizers and work by reducing hepatic glucose production and increasing glucose uptake by adipose and muscle tissue. Alpha-glucosidase inhibitors work to reduce the rate of digestion of starches, resulting in delayed absorption of glucose. Sulfonylureas, benzoic acid derivatives, and D-Phenylalanine derivatives are insulin secretogogues and work to increase the release of insulin from the pancreas (Monthly Prescribing Reference [MPR], 2(03). The goal of pharmacologic therapy is to match the medication with the pathophysiologic basis of the hyperglycemia.
Insulin Therapy
Insulin therapy is used for the treatment of type I diabetes and for individuals with type 2 diabetes who have been unable to achieve adequate glycemic control with oral agents and non-pharmacologic therapy. Insulin should also be used during pregnancy. Currently, oral agents are contraindicated during pregnancy. Insulin may be needed temporarily to manage type 2 diabetes during times of illness, stress, or trauma. Insulin is classified according to onset, peak, and duration of action (see Table 4 ).
The goal of insulin therapy is to mimic the normal physiologic profile of insulin secretion, providing insulin to meet the basal needs and bolus requirements in response to food intake (AADE, 2003) . This often AUGUST 2004, VOL. 52, NO.8 requires frequent injections of various insulin preparations throughout the day. The insulin user must have an understanding of insulin actions and how these incorporate into daily physical activity levels and food intake.
Insulin regimens are generally individualized to the needs of the person with diabetes in relation to meals, physical activity, work or school schedule, and emotional factors. Different mechanisms for insulin delivery are available to further meet individual needs. One mechanism, an insulin pump, delivers a pre programmed continuous infusion of insulin throughout the day, thus offering more flexibility with insulin administration.
Insulin storage guidelines vary depending on the preparation and mechanism of administration-a vial, insulin pen/cartridge, or insulin pump. It is important for individuals with diabetes to have a clear understanding of insulin storage and care of equipment. Training with a CDE can help to accomplish this educational need.
DIABETES SELF MANAGEMENT EDUCATION
Diabetes is a self managed chronic disease. Therefore, DSME is an essential component of diabetes care for individuals who want to achieve positive health related outcomes. Based on an individualized needs assessment, education will be offered on diabetes disease process; nutritional management; physical activity; medications; monitoring; acute and chronic complications; and pre conception care, management in pregnancy, or gestational diabetes. DSME is an ongoing process with collaboration between the employee and the health care team including the CDE, registered nurses, occupational health nurses, registered dietitians, pharmacists, and physicians. Referral to a diabetes educator is recommended at the initial diabetes management visit (ADA, 2004) . 
HYPOGLYCEMIA
Because of the difficulty duplicating normal body metabolism with diabetes medications, blood glucose levels tend to fluctuate, causing hyperglycemia and hypoglycemia. As medication regimens have become more intensive in an effort to achieve tight blood glucose control, hypoglycemia has become more significant. Hypoglycemia is the most common side effect of insulin and can occur in individuals taking sulfonylureas or meglitinides.
In general, hypoglycemia can be defined as a blood glucose level less than 70 mg/dL. Symptoms of hypoglycemia rather than blood glucose levels define the severity of hypoglycemia. A mild reaction can be treated quickly by eating or drinking food containing carbohydrates (see Table 5 ). Symptoms include sweating, lightheadedness, shakiness, difficulty concentrating, hunger, mood change, and fatigue.
Severe hypoglycemic reactions are those where the person is unable to self treat because of mental confusion, lethargy, seizure activity, or unconsciousness (AADE, 2003) . Another person must provide treatment using glucagon, available in a glucagon emergency kit containing a I mg single dose vial of glucagon powder, I mL of diluent, and a disposable syringe. This allows for quick reconstitution and administration. Glucagon works by increasing hepatic glucose production, elevating blood glucose levels (MPR, 2003) . As soon as the person awakens and is able to swallow, the health care provider or trained personnel should provide a fast acting carbohydrate source, followed by a mixed nutrient snack such as cheese and crackers or a meat sandwich.
RISK REDUCTION FOR CHRONIC COMPLICATIONS
Most of the morbidity and mortality associated with diabetes is caused by complications of the disease, blind-ness, kidney failure, nerve damage, cardiovascular disease, and other related conditions such as amputations and impotence. Providing care that leads to the best possible outcomes is key in delaying or preventing complications. Several outcome measures have been identified as a basis for measuring improved quality of care. These include interventions based on results of hemoglobin Al c, lipids, kidney function tests, blood pressure, dilated eye examination, foot assessment, and assessment of tobacco use (ADA, 2004) .
The Alc test measures the amount of glycosolation on a part of the hemoglobin in the red blood cells and is an indicator of blood glucose control during the past 2 to 3 months. This test is one of the most important predictors of risk for diabetes complications and should be performed every 3 to 6 months. Results outside of the recommended range may indicate a need for adjustments in medication, nutrition. or physical activity plans and referral to the CDE for additional diabetes self management training (ADA, 2004) .
Glycemic control is fundamental to diabetes management. Two studies, the Diabetes Control and Complications Trial (DCCT) (1993) and the United Kingdom Prospective Diabetes Study Group (1995) , showed that improved glycemic control, as demonstrated by improved A Ic levels, decreased or delayed onset of diabetes complications. Glycemic goals as set by the American Diabetes Association (2003) and the American Association of Clinical Endocrinologists (2003) are a basis for diabetes management decisions (see Table 6 ).
A lipid profile should be performed yearly and is also an important risk assessment tool because individuals with diabetes have death rates caused by heart disease and a risk for stroke two to four times higher than indi-viduals without diabetes (U.S. Department of Health and Human Services [USDHHSj, 2000) . The risk for a first major coronary event for a person with type 2 diabetes is nearly the same as for a person who has previously had a cardiac event (National Cholesterol Education Program, 2002) . Elevated lipid levels indicate a need for a meal plan supporting blood glucose control and reduced blood fats. Management may include an emphasis on physical activity, weight loss, smoking cessation, and referral to a registered dietitian for MNT. Lipid lowering medications are often prescribed (ADA, 2004) .
Convincing evidence exists that with early identification and certain interventions, kidney complications of diabetes can be reduced. Currently, diabetes is the leading cause of end stage renal disease, accounting for 43% of new cases (USDHHS, 2000) . Microalbuminuria is the earliest stage of diabetic nephropathy and has been shown to be an early predictor of cardiovascular disease. A test for microalbuminuria should be performed upon diagnosis and once a year. The importance of hypertension control should be emphasized in slowing down the progression of nephropathy (ADA, 2004) .
Hypertension contributes to the risk for long term complications of diabetes including heart disease, kidney disease, and diabetes related eye disease (DRED). Hypertension control has been shown to reduce cardiovascular disease and microvascular disease (e.g., retinopathy, nephropathy, neuropathy) (CDC, 2003) . A target blood pressure goal of less than 130/80 mmHg is suggested and should be evaluated at each visit. Basic information related to blood pressure control, including blood glucose control, physical activity, weight loss, dietary interventions, and smoking cessation should be emphasized (ADA, 2004) .
DRED is the leading cause of new cases of blindness among adults ages 20 to 74 and includes diabetic retinopathy, glaucoma, and cataracts. Blood glucose and blood pressure control and smoking cessation are important in preventing or delaying diabetic retinopathy. The DCCT demonstrated tight glycemic control reduced the risk for diabetic retinopathy among individuals with type I diabetes by 76% (DCCT Research Group, 1993) . Early detection through a yearly dilated eye examination is extremely important because DRED can be developing even when no vision changes have occurred. Treatment with laser therapy can reduce severe vision loss by an estimated 50% to 60% (CDC, 2003) . Lower extremity amputations were performed on 82,000 individuals with diabetes in the United States between 2000 and 200 I. Neuropathy affects approximately 60% to 70% of all individuals with diabetes and can cause loss of sensation in hands and feet, as well as slowed digestion, carpal tunnel syndrome, and impotence (CDC, 2003) . Severe forms of neuropathy and impaired circulation are primary causes of foot problems leading to amputation. Individuals with diabetes should have a complete foot examination by their health care provider at least once each year to detect high risk conditions. Daily self foot care is necessary to detect or prevent complications that might lead to lower extremity amputations. Individuals with diabetes should inspect their feet daily, use good hygiene practices (including nail and skin Adapted from ADA (2002) and AACE (2003) .
IN SUMMARY
2 Early recognition and treatment of diabetes is crucial for the prevention of diabetes complications, which have a negative impact on the employee's quality of life and increase absenteeism.
SUMMARY
Diabetes is common, serious, costly, and controllable. Current scientific evidence indicates much of the morbidity and mortality associated with diabetes can be eliminated through prevention, early detection, improved delivery of care, and better education for diabetes self management. Unfortunately, a wide gap still exists between current and desired diabetes care and practices. Using existing tools care), wear shoes that fit well, and treat minor foot injuries immediately. If a foot injury does not heal after one day, the health care provider should be notified (NDEP, 2000) .
Other complications of diabetes include diabetic ketoacidosis or hyperosmolar (non-ketotic) coma. Individuals with diabetes are often more susceptible to other illnesses, and after diagnosed, have a poorer prognosis. Therefore, it is important that interventions such as influenza and pneumonia vaccines and other preventive measures be encouraged to avoid negative outcomes.
